ICD-10 Coding for Chemotherapy-Induced Nausea and Vomiting(E86.0U, R11.10, R11.10B)
Learn about the ICD-10 coding for chemotherapy-induced nausea and vomiting, including documentation requirements and billing considerations.
Complete code families applicable to Chemotherapy-Induced Nausea and Vomiting
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R11.10 | Nausea with vomiting, unspecified | Use when both nausea and vomiting are present post-chemotherapy. |
|
| T45.1X5A | Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter | Use when symptoms are confirmed as adverse effects of chemotherapy. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutChemotherapy-Induced Nausea and Vomiting
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Chemotherapy-Induced Nausea and Vomiting.
Lack of explicit linkage between symptoms and chemotherapy
Impact
Clinical: Misrepresentation of patient condition., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.
Mitigation
Ensure documentation includes 'adverse effect' language.
Confusing adverse effect with poisoning
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Use T45.1X5A for correctly administered chemotherapy causing symptoms.
Documentation of adverse effects
Impact
Failure to document adverse effects accurately can lead to audit issues.
Mitigation
Ensure all symptoms are linked to chemotherapy with appropriate language.